Tianjin Pharmaceutical Da Ren Tang Group Stock Forecast

Sell candidate since Aug 11, 2026

The Tianjin Pharmaceutical Da Ren Tang Group stock price fell by -0.364% on the last day (Tuesday, 11th Aug 2026) from S$2.75 to S$2.74. During the last trading day the stock fluctuated 1.47% from a day low at S$2.73 to a day high of S$2.77. The price has fallen in 7 of the last 10 days and is down by -2.49% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -63 thousand shares and in total, 108 thousand shares were bought and sold for approximately S$296.19 thousand.

The stock lies the upper part of a wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at S$2.74 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Given the current short-term trend, the stock is expected to fall -18.26% during the next 3 months and, with a 90% probability hold a price between S$2.02 and S$2.24 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

T14.SI Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, July 07, 2026, and so far it has risen 1.11%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Tianjin Pharmaceutical Da Ren Tang Group stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at S$2.76 and S$2.81. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Tianjin Pharmaceutical Da Ren Tang Group stock

Tianjin Pharmaceutical Da Ren Tang Group finds support from accumulated volume at S$2.73 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved S$0.0400 between high and low, or 1.47%. For the last week the stock has had daily average volatility of 1.92%

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (T14.SI) For The Upcoming Trading Day Of Wednesday 12th

For the upcoming trading day on Wednesday, 12th we expect Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited to open at S$2.75, and during the day (based on 14 day Average True Range), to move between S$2.71 and S$2.77, which gives a possible trading interval of +/-S$0.0697 (+/-2.58%) up or down from last closing price. If Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited takes out the full calculated possible swing range there will be an estimated 2.58% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at S$2.75 (0.36%) than the support at S$2.73 (0.36%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited stock A Buy?

Tianjin Pharmaceutical Da Ren Tang Group holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Sell candidate.

Current score: -1.223 Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 12, 2026 - S$2.75 ( 0.243%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk